Trigeminal Nerve Sheath Tumor Presenting as a Cluster Headache

2018 ◽  
Vol 58 (6) ◽  
pp. 896-897
Author(s):  
Ario Mirian ◽  
Adrian Budhram ◽  
Andrew Leung ◽  
Michelle-Lee Jones
1979 ◽  
Vol 133 (1) ◽  
pp. 142-144 ◽  
Author(s):  
RM Quencer ◽  
NA Stokes ◽  
D Wolfe ◽  
LK Page

Neurosurgery ◽  
2006 ◽  
Vol 59 (2) ◽  
pp. E425-E425 ◽  
Author(s):  
Andreas M. Stark ◽  
Ralf Buhl ◽  
Heinz-Herrmann Hugo ◽  
Thorsten Straube ◽  
H Maximilian Mehdorn

Abstract OBJECTIVE: Clinically significant intratumoral or peritumoral bleeding from trigeminal nerve tumors is very rare. CLINICAL PRESENTATION: We report the case of a 59-year-old man who presented with recurrent subarachnoid hemorrhage from a left trigeminal nerve malignant peripheral nerve sheath tumor. He presented with decreased consciousness, left facial hypesthesia, and left facial weakness. Trigeminal neuralgia was present for 18 months. Cranial computed tomographic and magnetic resonance imaging scans revealed a left parapontine mass with cystic changes and intratumoral bleeding. Furthermore, signs of hemosiderosis of the subarachnoid space were noted. Lumbar puncture revealed fresh bleeding. Angiography detected no aneurysm or other causes of bleeding. The patient became fully alert within hours, the facial weakness improved within a few days. There was no evidence of vasospasm or persisting hydrocephalus. He underwent left-sided suboccipital craniotomy for macroscopically total tumor removal. INTERVENTION: The patient underwent total tumor removal via a left suboccipital approach. Intraoperatively, evidence of recurrent intratumoral bleeding was noted. Histological examination revealed a malignant peripheral nerve sheath tumor (World Health Organization Grade III). Postoperatively, the hypesthesia improved significantly. The patient was transferred to radiotherapy for external beam radiation. CONCLUSIONS: This is the first report regarding a malignant peripheral nerve sheath tumor of the trigeminal nerve that caused clinically significant subarachnoid hemorrhage caused by intratumoral bleeding.


2018 ◽  
Vol 112 ◽  
pp. 221-226 ◽  
Author(s):  
Aijun Liang ◽  
Bin Xi ◽  
Chaoyang Zhou ◽  
Yu Yang ◽  
Jianzhong Zhang ◽  
...  

2019 ◽  
Vol 17 (5) ◽  
pp. E205-E205
Author(s):  
Hussam Abou-Al-Shaar ◽  
Yair M Gozal ◽  
Jason P Hunt ◽  
William T Couldwell

Abstract Malignant peripheral nerve sheath tumors (MPNSTs) of the trigeminal nerve are uncommon lesions that pose a surgical challenge to neurosurgeons. The case described in this video involved a 67-yr-old man who presented with a 2-yr history of left-sided facial numbness spreading from his chin along the left mandible to the preauricular area. He also reported left-sided tongue numbness and decreased taste on the left side of the tongue. On examination, he had left-sided facial numbness along the V3 distribution to pinprick and light touch. Magnetic resonance imaging (MRI) revealed an enhancing left V3 lesion extending from Meckel's cave to the angle of the mandible. The patient underwent a left temporal craniotomy for biopsy of the lesion, formalizing the diagnosis of a MPNST of the left trigeminal nerve. A multidisciplinary resection of his lesion was performed. Left infratemporal fossa approach with neck dissection, mandibulectomy, and frontotemporal craniotomy were performed. Additionally, a frontal external ventricular drain was placed for 3 d to aid in CSF diversion to avoid CSF leak, and free-flap reconstruction was undertaken. The patient tolerated the procedure well. Postoperatively, he retained his facial numbness, dysphagia, and dysarthria. The patient was discharged to inpatient rehabilitation on postoperative day 12. Postoperative computed tomography and MRI depicted complete resection of the left trigeminal nerve MPNST. At his last follow-up appointment, 3 mo after surgery, the patient reported significant improvement in his symptoms. Neuroimaging demonstrated no residual tumor and adjuvant radiotherapy was recommended. The patient provided consent for publication.


1998 ◽  
Vol 34 (1) ◽  
pp. 19-25 ◽  
Author(s):  
RS Bagley ◽  
SJ Wheeler ◽  
L Klopp ◽  
DC Sorjonen ◽  
WB Thomas ◽  
...  

Nerve-sheath tumor was diagnosed in 10 dogs with clinical signs of unilateral trigeminal nerve dysfunction. Unilateral temporalis and masseter muscle atrophy were present in all cases. An enlarged foramen and distorted rostral petrous temporal bone were seen with computed tomography imaging in one case. Magnetic resonance imaging was used to identify the lesion accurately in seven cases. Surgery was performed for biopsy and lesion removal in three cases. Cases not treated had a progressive course eventually resulting in euthanasia or death. Of the cases treated surgically, one case is alive without disease progression 27 months after surgery. Survival times of the nontreated cases ranged from five to 21 months.


2014 ◽  
Vol 2014 ◽  
pp. 1-6
Author(s):  
Maher Kurdi ◽  
Hosam Al-Ardati ◽  
Saleh S. Baeesa

Background. The synchronous development of two primary brain tumors of distinct cell of origin in close proximity or in contact with each other is extremely rare. We present the first case of collision tumor with two histological distinct tumors.Case Presentation. A 54-year-old woman presented with progressive atypical left facial pain and numbness for 8 months. MRI of the brain showed left middle cranial fossa heterogeneous mass extending into the infratemporal fossa. At surgery, a distinct but intermingled intra- and extradural tumor was demonstrated which was completely removed through left orbitozygomatic-temporal craniotomy. Histopathological examination showed that the tumor had two distinct components: malignant nerve sheath tumor of the trigeminal nerve and temporal lobe anaplastic astrocytoma. Proliferative activity and expressed tumor protein 53 (TP53) gene mutations were demonstrated in both tumors.Conclusions. We describe the first case of malignant trigeminal nerve sheath tumor (MTNST) and anaplastic astrocytoma in collision and discuss the possible hypothesis of this rare occurrence. We propose that MTNST, with TP53 mutation, have participated in the formation of anaplastic astrocytoma, or vice versa.


2007 ◽  
Vol 27 (1) ◽  
pp. 29-31 ◽  
Author(s):  
Julio A Rodr??guez ◽  
Thomas R Hedges ◽  
Carl B Heilman ◽  
Mitchell B Strominger ◽  
Nora M Laver

2019 ◽  
Vol 2 (1) ◽  
Author(s):  
Zheng Melissa ◽  
Li Zhonghua ◽  
Mulvey Carolyn L ◽  
Staddon Arthur P ◽  
Kennedy David W ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document